Myriad Genetics, Inc. (MYGN)
After hours:
Chart Events
Performance Outlook
| Previous Close | 16.79 |
| Open | 16.97 |
| Bid | 15.54 x 1000 |
| Ask | 16.07 x 800 |
| Day's Range | 15.67 - 17.11 |
| 52 Week Range | 13.92 - 24.21 |
| Volume | |
| Avg. Volume | 513,492 |
| Market Cap | 1.313B |
| Beta (5Y Monthly) | 1.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.16 |
| Earnings Date | Oct 30, 2023 - Nov 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.72 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MYGN
Related Research
- Myriad Genetics, Inc.MYGN: Lowering target price to $14.00MYRIAD GENETICS INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.RatingFair ValueEconomic Moat3 days agoArgus Research
GuruFocus.comIs Myriad Genetics (MYGN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
Unpacking the Risks and Rewards of Investing in Myriad Genetics (MYGN)
PR NewswireBREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY REVEALS RISK FACTORS ARE WIDELY MISUNDERSTOOD
A new national survey from Myriad Genetics Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, revealed that breast density and family health history are two misunderstood breast cancer risk factors.
GlobeNewswireNew Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from a nationwide survey revealing breast density and family health history are two misunderstood breast cancer risk factors. The Myriad Genetics Cancer Risk Survey found that nearly half (48%) of the women surveyed do not know what breast density is, and 50% are unsure if breast density has anything to do with breast cancer risk. Wo
